RecentgroundbreakingresearchpublishedinNatureMicrobiologyhashighlightedthesignificantroleofAkkermansiamuciniphila(Akk)incombatingmetabolicdisorders.Thisrevelationcomesatacrucialtimewhenmetabolicdiseasessuchastype2diabetes,non-alcoholicfattyliverdisease,andmetabolicsyndromearerisingglobally.Thesecond

Intheworldofprobiotics,Akkermansiamuciniphilaisemergingasarevolutionaryplayerwithpromisingpotentialforenhancingguthealthandaidinginweightmanagement.AtWecareProbiotics.,wearededicatedtopioneeringtheresearch,development,production,andapplicationofinnovativeprobioticstrains.Ourfocusonintestinalflora,hu

AbstractThepatentdescribesthediscoveryandapplicationofaspecificstrainofLimosilactobacillusreuteri(LR38),preservedunderCGMCCNo.24408,whichiseffectiveinimprovingpolycysticovarysyndrome(PCOS).ThestrainaddressesPCOS-relatedsymptomssuchasmetabolicleveldisordersandabnormalsexhormonelevels,providingapotent

Human-residentialprobioticsarebeneficialmicroorganismsthatnaturallyresideinthehumanbody,particularlyinthegut.Theyplayacrucialroleinmaintaininghealthandwell-being.Breastmilkisaprimarysourceofprobioticsforinfants.Itcontainsbeneficialbacteriasuchasbifidobacteriaandlactobacilli,alongwithprebioticslikehu

IntroductionWeizmanniacoagulansBC99,anovelprobioticstrain,hasshownpotentialintreatinggastrointestinaldisorders,particularlychronicconstipation.Chronicconstipation,acommonailmentaffectingaround16%oftheglobalpopulation,severelyimpactsthequalityoflife.Thisclinicalstudyinvestigatestheefficacyandsafetyof

Abstract:ThisstudyexplorestheeffectsofLacticaseibacillusparacaseiLC86onage-relateddeclinesinmusclestrengthandcognitivefunctioninSAMP8mice.Chronicinflammationandgutmicrobiotacompositionarekeyfactorsinthesedeclines.TheadministrationofLC86over12weekssignificantlyimprovedmusclestrength,cognitiveperforma